Inventor · disambiguated record
Gary R. Ostroff
Also filed as: OSTROFF GARY · OSTROFF GARY R
43 granted patents·18 pending applications·2,114 citations·filing 1983–2025
98Inventor score
Files withUNIV MASSACHUSETTS17ALPHA BETA TECHNOLOGY15OSTROFF GARY R6EDEN RESEARCH PLC5FRANKLIN LANNY4
Top patents by PatentIndex Score
61 records- 0198US5607677AGlucan drug delivery system and adjuvantALPHA BETA TECHNOLOGY·Filed 1990·Granted Mar 4, 1997·321 cites·1 claims
- 0298US5032401AGlucan drug delivery system and adjuvantALPHA BETA TECHNOLOGY·Filed 1989·Granted Jul 16, 1991·297 cites·6 claims
- 0396US5504079AMethod for immune system activation by administration of a β(1-3) glucan which is produced by Saccharomyces cerevisiae strain R4ALPHA BETA TECHNOLOGY·Filed 1994·Granted Apr 2, 1996·180 cites·6 claims
- 0495US5741495AGlucan drug delivery system and adjuvantALPHA BETA TECHNOLOGY·Filed 1997·Granted Apr 21, 1998·152 cites·2 claims
- 0595US5622939AGlucan preparationALPHA BETA TECHNOLOGY·Filed 1992·Granted Apr 22, 1997·104 cites·35 claims
- 0694US10729130B2Nematicidal compositions and methods of using themEDEN RESEARCH PLC·Filed 2018·Granted Aug 4, 2020·4 cites·20 claims
- 0794US5817643AUnderivatized, aqueous soluable β(1-3) glucan, composition and method of making sameALPHA BETA TECHNOLOGY·Filed 1995·Granted Oct 6, 1998·93 cites·30 claims
- 0894US5322841AMethod for producing neutral glucans for pharmaceutical applicationsALPHA BETA TECHNOLOGY·Filed 1992·Granted Jun 21, 1994·109 cites·28 claims
- 0993US11826389B2Purified anthelmintic compositions and related methodsUNIV MASSACHUSETTS·Filed 2022·Granted Nov 28, 2023·2 cites·20 claims
- 1093US5783569AUses for underivatized, aqueous soluble β(1-3) glucan and compositions comprising sameALPHA BETA TECHNOLOGY·Filed 1993·Granted Jul 21, 1998·78 cites·87 claims
- 1192US10004229B2Nematicidal compositions and methods of using themEDEN RESEARCH PLC·Filed 2017·Granted Jun 26, 2018·3 cites·19 claims
- 1292US9655360B2Nematicidal compositions and methods of using themFRANKLIN LANNY·Filed 2005·Granted May 23, 2017·9 cites·24 claims
- 1392US9439416B2Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral, and l-carvoneFRANKLIN LANNY·Filed 2006·Granted Sep 13, 2016·10 cites·22 claims
- 1492US7740861B2Drug delivery product and methodsUNIV MASSACHUSETTS·Filed 2004·Granted Jun 22, 2010·37 cites·55 claims
- 1591US7022685B2Very high molecular weight β-glucansBIOPOLYMER ENGINEERING INC·Filed 2002·Granted Apr 4, 2006·43 cites·12 claims
- 1691US5811542AMethod for producing soluble glucansALPHA BETA TECHNOLOGY·Filed 1995·Granted Sep 22, 1998·82 cites·22 claims
- 1789US6369216B1Very high molecular weight β-glucansBIOPOLYMER ENGINEERING PHARMAC·Filed 1999·Granted Apr 9, 2002·78 cites·16 claims
- 1889US5532223AUse of aqueous soluble glucan preparations to stimulate platelet productionALPHA BETA TECHNOLOGY·Filed 1995·Granted Jul 2, 1996·80 cites·32 claims
- 1988US8580275B2Drug delivery product and methodsOSTROFF GARY R·Filed 2010·Granted Nov 12, 2013·10 cites·53 claims
- 2088US5849720AEnhancement of non-specific immune defenses by administration of underivatized, aqueous soluble glucansALPHA BETA TECHNOLOGY·Filed 1995·Granted Dec 15, 1998·78 cites·10 claims
- 2188US5488040AUse of neutral soluble glucan preparations to stimulate platelet productionALPHA BETA TECHNOLOGY·Filed 1993·Granted Jan 30, 1996·79 cites·2 claims
- 2287US5622940AInhibition of infection-stimulated oral tissue destruction by β(1,3)-glucanALPHA BETA TECHNOLOGY·Filed 1994·Granted Apr 22, 1997·84 cites·30 claims
- 2386US11844815B2Purified anthelmintic compositions and related methodsUNIV MASSACHUSETTS·Filed 2018·Granted Dec 19, 2023·2 cites·26 claims
- 2486US10638750B2Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using themFRANKLIN LANNY·Filed 2005·Granted May 5, 2020·4 cites·23 claims
- 2585US9662299B2Yeast cell wall particles for receptor-targeted nanoparticle deliveryUNIV MASSACHUSETTS·Filed 2015·Granted May 30, 2017·3 cites·22 claims
- 2685US7566704B2Very high molecular weight β-glucansBIOPOLYMER ENGINEERING INC·Filed 2006·Granted Jul 28, 2009·5 cites·3 claims
- 2785US5663324AMethod for producing underivatized, aqueous soluble β(1-3) glucanALPHA BETA TECHNOLOGY·Filed 1995·Granted Sep 2, 1997·58 cites·33 claims
- 2885US5633369AMethod for producing soluble glucansALPHA BETA TECHNOLOGY·Filed 1995·Granted May 27, 1997·57 cites·24 claims
- 2984US12290539B2Purified anthelmintic compositions and related methodsUNIV MASSACHUSETTS·Filed 2023·Granted May 6, 2025·0 cites·33 claims
- 3081US11484568B2Anthelmintic compositions and methodsUNIV MASSACHUSETTS·Filed 2017·Granted Nov 1, 2022·4 cites·12 claims
- 3179US10667512B2Terpene-containing compositions and methods of making and using themFRANKLIN LANNY·Filed 2006·Granted Jun 2, 2020·1 cites·29 claims
- 3278US8007814B2Therapy for lysosomal enzyme deficienciesUNIV MASSACHUSETTS·Filed 2005·Granted Aug 30, 2011·3 cites·31 claims
- 3377US9242857B2Yeast cell wall particles for receptor-targeted nanoparticle deliveryOSTROFF GARY R·Filed 2011·Granted Jan 26, 2016·2 cites·15 claims
- 3477US8389485B2Encapsulated nanoparticles for nucleic acid deliveryCZECH MICHAEL P·Filed 2008·Granted Mar 5, 2013·6 cites·38 claims
- 3575US10258033B2Compositions and methods comprising terpenes or terpene mixtures selected from thymol, eugenol, geraniol, citral and L-carvoneEDEN RESEARCH PLC·Filed 2014·Granted Apr 16, 2019·2 cites·15 claims
- 3675US8637045B2Therapy for lysosomal enzyme deficienciesGINNS EDWARD I·Filed 2011·Granted Jan 28, 2014·5 cites·26 claims
- 3772US7786094B2Use of beta-glucans against biological warfare weapons and pathogens including anthraxBIOPOLYMER ENGINEERING INC·Filed 2002·Granted Aug 31, 2010·5 cites·11 claims
- 3870US8865679B2Use of beta-glucans against biological warfare weapons and pathogens including anthraxOSTROFF GARY R·Filed 2010·Granted Oct 21, 2014·1 cites·12 claims
- 3970US8563531B2Methods of using beta glucan as a radioprotective agentOSTROFF GARY R·Filed 2008·Granted Oct 22, 2013·1 cites·26 claims
- 4069US2010166751A1Cancer therapy using whole glucan particles and antibodiesBIOPOLYMER ENGINEERING D B A B·Filed 2009·Application pending·0 cites
- 4169US2025161373A1Purified anthelmintic compositions and related methodsUNIV MASSACHUSETTS·Filed 2025·Application pending·0 cites
- 4265US2023413823A1Hyperloaded yeast cell wall particle and uses thereofUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 4363US2024350419A1Oral room-temperature stable yeast particles (yp) and methods of useUNIV MASSACHUSETTS·Filed 2024·Application pending·0 cites
- 4462US2020315169A1Terpene-containing compositions and methods of making and using themEDEN RESEARCH PLC·Filed 2020·Application pending·0 cites
- 4561US9682135B2Drug delivery product and methodsUNIV MASSACHUSETTS·Filed 2013·Granted Jun 20, 2017·0 cites·15 claims
- 4661US2024058275A1Nano-silica - in yeast particle (yp) drug encapsulation approach for improved thermal and hydrolase stability of yp drug delivery formulationsUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 4761US2024058403A1Yeast particles for delivery of water-activated self-emulsifying cannabinoid formulationsUNIV MASSACHUSETTS·Filed 2023·Application pending·0 cites
- 4858US4595660AMolecular cloning with bifunctional plasmid vectors in Bacillus subtilis, mutants and substantially stably transformed mutants of Bacillus subtilis, and methods for utilizing the transformed mutantsUNIV DELAWARE·Filed 1983·Granted Jun 17, 1986·16 cites·8 claims
- 4958US2020236927A1Compositions containing a hollow glucan particle or a cell wall particle encapsulating a terpene component, methods of making and using themEDEN RESEARCH PLC·Filed 2020·Application pending·0 cites
- 5057US2017326071A1Yeast cell wall particles for receptor-targeted nanoparticle deliveryUNIV MASSACHUSETTS·Filed 2017·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Gary R. Ostroff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →